Oncotelic Therapeutics (OTLC) Stock Chart & Stock Price History → Trump convicted... now what? (From Stansberry Research) (Ad) Free OTLC Stock Alerts $0.04 0.00 (-2.67%) (As of 06/7/2024 08:53 PM ET) Add Compare Share Share ChartStock AnalysisChartFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartFinancialsHeadlinesSEC FilingsShort Interest Oncotelic Therapeutics Stock Price Performance5 Day Performance-1.35%1 Month Performance-4.58%3 Month Performance-13.10%6 Month Performance-6.31%Year-To-Date Performance-4.58%1 Year Performance+10.61% Receive OTLC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. But while the Left celebrates his conviction... and the Right rallies around him... the average American is not prepared for what happens next.Which is why it's so important to access this presentation while it's still available online. OTLC Stock Chart for Monday, June, 10, 2024 OTLC Chart by TradingView Oncotelic Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$0.04$0.04-2.67%$0.04$0.0464,500 shs$14.83 million06/06/2024$0.04$0.04+1.35%$0.04$0.0440,276 shs$15.24 million06/05/2024$0.04$0.04$0.04$0.04184,092 shs$15.03 million06/04/2024$0.04$0.04-1.60%$0.04$0.04184,092 shs$15.03 million06/03/2024$0.04$0.04+1.35%$0.04$0.043,397 shs$15.28 million05/31/2024$0.04$0.04-4.87%$0.04$0.0455,500 shs$15.07 million Get the Latest News and Ratings for OTLC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$0.04$0.04+5.41%$0.04$0.04112,391 shs$15.85 million05/29/2024$0.04$0.04-2.63%$0.04$0.0471,000 shs$15.03 million05/28/2024$0.04$0.04+2.70%$0.04$0.0411,736 shs$15.44 million05/27/2024$0.04$0.04$0.04$0.04265,500 shs$15.03 million05/24/2024$0.04$0.04+2.78%$0.04$0.04265,500 shs$15.03 million05/23/2024$0.04$0.04-1.64%$0.04$0.04101,040 shs$14.63 million05/22/2024$0.04$0.04-3.02%$0.04$0.04245,079 shs$14.59 million05/21/2024$0.04$0.04-2.73%$0.04$0.04238,001 shs$15.05 million05/20/2024$0.04$0.04+2.11%$0.04$0.04125,887 shs$15.47 million05/17/2024$0.04$0.04+1.33%$0.04$0.04106,436 shs$15.15 million05/16/2024$0.04$0.04+4.17%$0.04$0.041,535 shs$14.95 million05/15/2024$0.04$0.04-7.69%$0.04$0.0458,266 shs$14.35 million05/14/2024$0.04$0.04+1.17%$0.04$0.0410,475 shs$15.55 million05/13/2024$0.04$0.04+0.78%$0.04$0.0434,000 shs$15.37 million05/10/2024$0.04$0.04-1.29%$0.04$0.0433,032 shs$15.25 million05/09/2024$0.04$0.04-1.65%$0.04$0.041,022 shs$15.45 million05/08/2024$0.04$0.04+4.79%$0.04$0.045,064 shs$15.71 million05/07/2024$0.04$0.04-1.05%$0.04$0.04535 shs$14.99 million05/06/2024$0.04$0.04-3.55%$0.04$0.042,501 shs$15.15 million05/03/2024$0.04$0.04+2.87%$0.04$0.0421,310 shs$15.71 million05/02/2024$0.04$0.04-1.29%$0.04$0.04505 shs$15.27 million05/01/2024$0.04$0.04-2.88%$0.04$0.041,267 shs$15.47 million04/30/2024$0.04$0.04-4.88%$0.04$0.0493,465 shs$15.93 million04/29/2024$0.04$0.04$0.04$0.049,635 shs$16.74 million04/26/2024$0.04$0.04+2.94%$0.04$0.0422,308 shs$16.74 million04/25/2024$0.04$0.04+7.37%$0.04$0.0410,259 shs$16.27 million04/24/2024$0.04$0.04+5.56%$0.04$0.045,509 shs$15.15 million04/23/2024$0.04$0.04-8.63%$0.04$0.041,174 shs$14.35 million04/22/2024$0.04$0.04$0.04$0.043,500 shs$15.71 million04/19/2024$0.04$0.04-6.19%$0.04$0.0435,004 shs$15.71 million04/18/2024$0.04$0.04+2.69%$0.04$0.04104,764 shs$16.74 million04/17/2024$0.04$0.04-0.49%$0.04$0.0461,129 shs$16.31 million04/16/2024$0.04$0.04$0.04$0.0420,600 shs$16.39 million04/15/2024$0.04$0.04+0.24%$0.04$0.0412,750 shs$16.39 millionTrump convicted... now what? (Ad)Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. But while the Left celebrates his conviction... and the Right rallies around him... the average American is not prepared for what happens next.Which is why it's so important to access this presentation while it's still available online.04/12/2024$0.04$0.04$0.04$0.0425,025 shs$16.35 million04/11/2024$0.04$0.04$0.04$0.0439,869 shs$16.35 million04/10/2024$0.04$0.04-1.44%$0.04$0.0453,601 shs$16.35 million04/09/2024$0.04$0.04-0.95%$0.04$0.04522,365 shs$16.59 million04/08/2024$0.04$0.04+5.00%$0.04$0.0411,394 shs$16.74 million04/05/2024$0.04$0.04+10.51%$0.04$0.04330,773 shs$16.35 million04/04/2024$0.04$0.04+4.51%$0.04$0.0484,600 shs$14.79 million04/03/2024$0.04$0.04+0.57%$0.04$0.046,512 shs$14.15 million04/02/2024$0.04$0.04-9.25%$0.04$0.031,500 shs$14.07 million04/01/2024$0.04$0.04+8.12%$0.04$0.0449,491 shs$15.51 million03/29/2024$0.04$0.04-0.06%$0.04$0.0374,470 shs$14.34 million03/28/2024$0.04$0.04$0.04$0.0312,017 shs$14.35 million03/27/2024$0.04$0.04-8.86%$0.04$0.0412,017 shs$14.35 million03/26/2024$0.04$0.04+7.63%$0.04$0.0356,834 shs$15.75 million03/25/2024$0.04$0.04+0.14%$0.04$0.031,622 shs$14.63 million03/22/2024$0.04$0.04-2.01%$0.04$0.0320,642 shs$14.61 million03/21/2024$0.04$0.04+0.54%$0.04$0.0323,900 shs$14.91 million03/20/2024$0.04$0.04+2.48%$0.04$0.0364,074 shs$14.83 million03/19/2024$0.04$0.04+3.71%$0.04$0.0342,816 shs$14.47 million03/18/2024$0.04$0.04-5.66%$0.04$0.03319,464 shs$13.95 million03/15/2024$0.04$0.04-11.67%$0.04$0.0417,175 shs$14.79 million03/14/2024$0.04$0.04+10.53%$0.04$0.045,009 shs$16.72 million03/13/2024$0.04$0.04-9.52%$0.04$0.048,500 shs$15.13 million03/12/2024$0.04$0.04$0.04$0.0422,500 shs$16.72 million03/11/2024$0.04$0.04$0.04$0.0425 shs$16.72 million Related Companies: CALC Stock Price Chart ETST Stock Price Chart LPTX Stock Price Chart CELU Stock Price Chart THTX Stock Price Chart BLRX Stock Price Chart RPHM Stock Price Chart ANEB Stock Price Chart MURA Stock Price Chart CARM Stock Price Chart Receive OTLC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oncotelic Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:OTLC) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAlert: Your Bank is Dying – Act Now or Lose Everything!Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put...Priority Gold | SponsoredTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncotelic Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncotelic Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.